OPKO Health Total Assets 2010-2023 | OPK

OPKO Health total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Assets
(Millions of US $)
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.857B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.324B 25.46
Intuitive Surgical (ISRG) United States $130.862B 78.83
Edwards Lifesciences (EW) United States $52.344B 34.65
DexCom (DXCM) United States $50.703B 87.10
IQVIA Holdings (IQV) United States $41.988B 24.90
IDEXX Laboratories (IDXX) United States $39.830B 47.62
Alcon (ALC) Switzerland $39.749B 29.31
STERIS (STE) Ireland $19.852B 23.50
Hologic (HOLX) United States $17.891B 19.75
Waters (WAT) United States $17.747B 25.47
SONOVA HOLDING (SONVY) Switzerland $16.624B 0.00
ShockWave Medical (SWAV) United States $12.289B 84.91
Fresenius Medical Care AG KGaA (FMS) Germany $12.059B 14.89
Sysmex ADR (SSMXY) Japan $9.956B 31.22
Teleflex (TFX) United States $9.763B 15.33
Penumbra (PEN) United States $7.857B 97.13
Masimo (MASI) United States $7.107B 39.86
Globus Medical (GMED) United States $6.938B 22.00
Glaukos (GKOS) United States $4.966B 0.00
Integer Holdings (ITGR) United States $3.908B 24.98
LivaNova (LIVN) United Kingdom $2.914B 19.22
TransMedics (TMDX) United States $2.830B 0.00
Elekta AB (EKTAY) Sweden $2.660B 18.25
PROCEPT BioRobotics (PRCT) United States $2.609B 0.00
Nihon Kohden (NHNKY) Japan $2.368B 20.03
Integra LifeSciences Holdings (IART) United States $2.278B 9.35
Inari Medical (NARI) United States $2.198B 379.30
Tandem Diabetes Care (TNDM) United States $2.049B 0.00
RxSight (RXST) United States $1.936B 0.00
Alphatec Holdings (ATEC) United States $1.765B 0.00
Veracyte (VCYT) United States $1.490B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.876B 16.20
Artivion (AORT) United States $0.837B 96.76
Paragon 28 (FNA) United States $0.812B 0.00
OrthoPediatrics (KIDS) United States $0.718B 0.00
Treace Medical Concepts (TMCI) United States $0.685B 0.00
Silk Road Medical (SILK) United States $0.682B 0.00
SiBone (SIBN) United States $0.639B 0.00
Mesa Laboratories (MLAB) United States $0.552B 18.73
IRadimed (IRMD) United States $0.536B 31.15
ORTHOFIX MEDICAL INC (OFIX) United States $0.489B 0.00
Nevro (NVRO) United States $0.450B 0.00
Pacific Biosciences Of California (PACB) United States $0.418B 0.00
Pulse Biosciences (PLSE) United States $0.378B 0.00
NeuroPace (NPCE) United States $0.368B 0.00
Tactile Systems Technology (TCMD) United States $0.348B 11.72
CVRx (CVRX) United States $0.317B 0.00
AxoGen (AXGN) United States $0.300B 0.00
Sight Sciences (SGHT) United States $0.266B 0.00
EDAP TMS S.A (EDAP) France $0.265B 0.00
AngioDynamics (ANGO) United States $0.251B 0.00
Accuray (ARAY) United States $0.215B 0.00
Semler Scientific (SMLR) United States $0.185B 9.95
908 Devices (MASS) United States $0.184B 0.00
Atossa Genetics (ATOS) United States $0.178B 0.00
Alpha Tau Medical (DRTS) Israel $0.170B 0.00
Inogen (INGN) United States $0.158B 0.00
ClearPoint Neuro (CLPT) United States $0.149B 0.00
Delcath Systems (DCTH) United States $0.140B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Envoy Medical (COCH) United States $0.099B 0.00
KORU Medical Systems (KRMD) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.059B 0.00
Autonomix Medical (AMIX) United States $0.057B 0.00
Sensus Healthcare (SRTS) United States $0.056B 113.00
Vasomedical (VASO) United States $0.051B 9.17
Vicarious Surgical (RBOT) United States $0.048B 0.00
InspireMD (NSPR) Israel $0.045B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.042B 0.00
DarioHealth (DRIO) United States $0.039B 0.00
LENSAR (LNSR) United States $0.037B 0.00
Rapid Micro Biosystems (RPID) United States $0.037B 0.00
Lucid Diagnostics (LUCD) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
T2 Biosystems (TTOO) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.017B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00